Testing a New Way to Precisely Target and Predict the Impact of TMS Brain Stimulation for Depression

As non-invasive brain stimulation—variations of TMS (transcranial magnetic stimulation)—continues to evolve and is administered to a growing number of patients with depression (and other illnesses,…
Read More

Researchers say they have identified an objective biomarker of recovery in major depression that in a small cohort of treatment-resistant patients was able (on an ongoing basis) to capture whether…
Read More

In their efforts to understand the beneficial effects of SAINT, an important new fast-acting brain stimulation treatment for refractory major depression, researchers now think they understand why it…
Read More

Over the last decade, rTMS (repetitive transcranial magnetic stimulation), a form of non-invasive brain stimulation, has become a first-line treatment option for depressed patients, including those…
Read More

Depression among people diagnosed with multiple sclerosis (MS) has been estimated to be about three times more common than in the general population. No one knows why. It may well be true that…
Read More